Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Quidel's molecular diagnostic test- Quidel molecular hMPV assay- for the detection of Human Metapneumovirus (hMPV), has secured FDA approval.
Subscribe to our email newsletter
The approval allows the company to market its Quidel molecular hMPV assay in the US.
The company’s molecular product line offers reagents that provide for simple transport and storage of the kit, convenient workflow and a short time to result.
Quidel president and CEO Douglas Bryant said they are pleased about the approval of its first molecular offering in the US, and are excited with their continued execution of the R&D pipeline.
In September 2011 Quidel molecular hMPV assay secured CE Mark approval.